Notice
通知公告
世界中联临床用药安全专业委员会《雷公藤多苷片治疗慢性肾脏病安全用药指南》立项通知
发布时间：2022-01-24
阅读量：3959
世界中医药学会联合会
世界中医药学会联合会专业委员会标准
立项通知
WorldFederation of Chinese Medicine Societies
Announcementfor Specialty Committee Standards
世界中医药学会联合会批准临床用药安全专业委员会提交的《雷公藤多苷片治疗慢性肾脏病安全用药指南》（SCM-C/NP 0190-2022）立项，现予通知。
The SCM-Cstandard (SCM-C/NP 0190-2022) of Guidelinefor safe use of Tripterygium Glycosides Tablets in chronic kidney diseaseproposed bySpecialtyCommittee of clinical drug safety research of WFCMS was initiated by WorldFederation of Chinese Medicine Societies and were now effective.
世界中医药学会联合会
World Federation of Chinese MedicineSocieties
二〇二二年一月十七日
January 17th, 2022
